These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38629420)

  • 21. Percutaneous coronary intervention or medical therapy in patients with severe aortic stenosis and coronary artery disease undergoing transcatheter aortic valve implantation: a real-world analysis using data from an international network.
    Nunes RAB; Alves da Costa LM; Scudeler TL; de Carvalho Cantarelli MJ; Castello H; de Figueiredo Oliveira GB; Avezum Junior Á
    Coron Artery Dis; 2023 Mar; 34(2):134-137. PubMed ID: 36720022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease.
    Zimmermann FM; De Bruyne B; Pijls NH; Desai M; Oldroyd KG; Park SJ; Reardon MJ; Wendler O; Woo J; Yeung AC; Fearon WF
    Am Heart J; 2015 Oct; 170(4):619-626.e2. PubMed ID: 26386784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term variations of FFR and iFR after transcatheter aortic valve implantation.
    Scarsini R; Lunardi M; Venturi G; Pighi M; Tavella D; Pesarini G; Ribichini F
    Int J Cardiol; 2020 Oct; 317():37-41. PubMed ID: 32504719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of clinical outcomes following percutaneous coronary intervention versus optimal medical therapy based on gray-zone fractional flow reserve in stable angina patients with intermediate coronary artery stenosis (COMFORTABLE prospective study): Study protocol for a multicenter randomized controlled trial.
    Kitabata H; Kubo T; Shiono Y; Shimamura K; Ino Y; Tanimoto T; Hayashi Y; Komukai K; Sougawa H; Kimura K; Gohda M; Hashizume T; Obana M; Maeda K; Yamaguchi J; Akasaka T
    Trials; 2019 Jan; 20(1):84. PubMed ID: 30691507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fractional flow reserve evaluation in patients considered for transfemoral transcatheter aortic valve implantation: a case series.
    Stähli BE; Maier W; Corti R; Lüscher TF; Altwegg LA
    Cardiology; 2012; 123(4):234-9. PubMed ID: 23208417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation.
    Costa G; Pilgrim T; Amat Santos IJ; De Backer O; Kim WK; Barbosa Ribeiro H; Saia F; Bunc M; Tchetche D; Garot P; Ribichini FL; Mylotte D; Burzotta F; Watanabe Y; De Marco F; Tesorio T; Rheude T; Tocci M; Franzone A; Valvo R; Savontaus M; Wienemann H; Porto I; Gandolfo C; Iadanza A; Bortone AS; Mach M; Latib A; Biasco L; Taramasso M; Zimarino M; Tomii D; Nuyens P; Sondergaard L; Camara SF; Palmerini T; Orzalkiewicz M; Steblovnik K; Degrelle B; Gautier A; Del Sole PA; Mainardi A; Pighi M; Lunardi M; Kawashima H; Criscione E; Cesario V; Biancari F; Zanin F; Joner M; Esposito G; Adam M; Grube E; Baldus S; De Marzo V; Piredda E; Cannata S; Iacovelli F; Andreas M; Frittitta V; Dipietro E; Reddavid C; Strazzieri O; Motta S; Angellotti D; Sgroi C; Kargoli F; Tamburino C; Barbanti M;
    Circ Cardiovasc Interv; 2022 Dec; 15(12):e012417. PubMed ID: 36538579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcatheter aortic valve implantation combined with elective coronary artery stenting: a simultaneous approach†.
    Penkalla A; Pasic M; Drews T; Buz S; Dreysse S; Kukucka M; Mladenow A; Hetzer R; Unbehaun A
    Eur J Cardiothorac Surg; 2015 Jun; 47(6):1083-9. PubMed ID: 25217500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.
    Huczek Z; Zbroński K; Grodecki K; Scisło P; Rymuza B; Kochman J; Dąbrowski M; Witkowski A; Wojakowski W; Parma R; Ochała A; Grygier M; Olasińska-Wiśniewska A; Araszkiewicz A; Jagielak D; Ciećwierz D; Puchta D; Paczwa K; Filipiak KJ; Wilimski R; Zembala M; Opolski G
    Catheter Cardiovasc Interv; 2018 Jan; 91(1):115-123. PubMed ID: 28843025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary revascularization and TAVI: before, during, after or never?
    O'Sullivan CJ; Stefanini GG; Stortecky S; Tüller D; Windecker S; Wenaweser P
    Minerva Med; 2014 Dec; 105(6):475-85. PubMed ID: 25274461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-Analysis Comparing Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation With Versus Without Percutaneous Coronary Intervention.
    Lateef N; Khan MS; Deo SV; Yamani N; Riaz H; Virk HUH; Khan SU; Hedrick DP; Kanaan A; Reed GW; Krishnaswamy A; Puri R; Kapadia SR; Kalra A
    Am J Cardiol; 2019 Dec; 124(11):1757-1764. PubMed ID: 31575422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
    Lunardi M; Venturi G; Del Sole PA; Ruzzarin A; Mainardi A; Pighi M; Pesarini G; Scarsini R; Tavella D; Gottin L; Ribichini FL
    Int J Cardiol; 2022 Oct; 365():114-122. PubMed ID: 35870638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protected Percutaneous Coronary Intervention of Unprotected Left Main Using Impella Ventricular Assist Device Before Transcatheter Aortic Valve Implantation: A Single-Center Experience.
    Kneizeh K; Alnaimi A; Noterdaeme T; Schröder J; Altiok E; Marx N; Almalla M
    J Invasive Cardiol; 2022 Mar; 34(3):E196-E201. PubMed ID: 35058376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of coronary lesions and its revascularization in a 5-year follow-up after the TAVI procedure.
    Vázquez DJL; López GA; Guzmán MQ; Cancelo AV; Leal FR; Rios XF; Esteban PP; Fernandez JS; Santos RC; Rodriguez JMV
    Catheter Cardiovasc Interv; 2023 Sep; 102(3):513-520. PubMed ID: 37471716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of coronary artery disease and percutaneous coronary intervention on mid-term outcomes in patients with aortic valve stenosis treated with transcatheter aortic valve implantation.
    Kaihara T; Higuma T; Izumo M; Kotoku N; Suzuki T; Kameshima H; Sato Y; Kuwata S; Koga M; Mitarai T; Watanabe M; Okuyama K; Kamijima R; Ishibashi Y; Yoneyama K; Tanabe Y; Harada T; Akashi YJ
    Clin Cardiol; 2021 Aug; 44(8):1089-1097. PubMed ID: 34033124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of concomitant coronary artery disease in patients undergoing transcatheter aortic valve implantation: the United Kingdom TAVI Registry.
    Snow TM; Ludman P; Banya W; DeBelder M; MacCarthy PM; Davies SW; Di Mario C; Moat NE
    Int J Cardiol; 2015 Nov; 199():253-60. PubMed ID: 26209948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical versus Interventional Treatment of Concomitant Aortic Valve Stenosis and Coronary Artery Disease.
    Elderia A; Gerfer S; Eghbalzadeh K; Adam M; Baldus S; Rahmanian P; Kuhn E; Wahlers T
    Thorac Cardiovasc Surg; 2023 Dec; 71(8):620-631. PubMed ID: 36549305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.
    Guedeney P; Tchétché D; Petronio AS; Mehilli J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Iadanza A; Sardella G; Van Mieghem NM; Sorrentino S; Claessen BEPM; Chandrasekhar J; Vogel B; Kalkman DN; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Ferrer-Grazia MC; Naber C; Kievit P; Baber U; Sharma S; Morice MC; Chieffo A; Mehran R;
    Catheter Cardiovasc Interv; 2019 May; 93(6):1124-1131. PubMed ID: 30511802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Effects of Transcatheter Aortic Valve Implantation on Coronary Hemodynamics in Patients With Concomitant Coronary Artery Disease and Severe Aortic Stenosis.
    Vendrik J; Ahmad Y; Eftekhari A; Howard JP; Wijntjens GWM; Stegehuis VE; Cook C; Terkelsen CJ; Christiansen EH; Koch KT; Piek JJ; Sen S; Baan J
    J Am Heart Assoc; 2020 Mar; 9(5):e015133. PubMed ID: 32102615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice.
    Van Mieghem NM; van der Boon RM; Faqiri E; Diletti R; Schultz C; van Geuns RJ; Serruys PW; Kappetein AP; van Domburg RT; de Jaegere PP
    JACC Cardiovasc Interv; 2013 Aug; 6(8):867-75. PubMed ID: 23871511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative flow ratio-guided strategy versus angiography-guided strategy for percutaneous coronary intervention: Rationale and design of the FAVOR III China trial.
    Song L; Tu S; Sun Z; Wang Y; Ding D; Guan C; Xie L; Escaned J; Fearon WF; Kirtane AJ; Serruys PW; Wijns W; Windecker S; Leon MB; Stone GW; Qiao S; Xu B;
    Am Heart J; 2020 May; 223():72-80. PubMed ID: 32179258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.